Malignant Musculoskeletal Neoplasm — Trials

Malignant Musculoskeletal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

465 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 141
Recruiting: 73
Ph III recruiting: 6
Growth YoY: −28%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (58)

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02508038	Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors	recruiting	Phase 1	22	University of Wisconsin, MadisonOTHER	1	Oct 16, 2025	clinicaltrials
NCT07066982	Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas(BAH2573-103)	recruiting	Phase 1 / Phase 2	60	Essen BiotechOTHER	1	Jul 15, 2025